Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism
Xintong Zhang, Yulong Shi, Zhihao Guo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114209-114209
Open Access | Times Cited: 12

Showing 12 citing articles:

Clofazimine for the treatment of tuberculosis
Jacob A. M. Stadler, Gary Maartens, Graeme Meintjes, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 35
Clofazimine: A journey of a drug
Jiabin Xu, Alexey Koval, Vladimir L. Katanaev
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115539-115539
Open Access | Times Cited: 10
Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs
Zhiwen Li, Zhihao Guo, Xi Lü, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 7, pp. 3067-3079
Open Access | Times Cited: 5
The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein
Matthew R. Freidel, Pratiti A. Vakhariya, Shalinder K. Sardarni, et al.
(2024)
Open Access | Times Cited: 1
Application of engineered myoglobins for biosynthesis of clofazimine by integration with chemical synthesis
Shuai Tang, Lijuan Sun, Ai-Qun Pan, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 48, pp. 9603-9609
Closed Access | Times Cited: 3
Screening for inhibitors against SARS-CoV-2 and its variants
Weijing Yuan, Xiaojing Dong, Lan Chen, et al.
Biosafety and Health (2022) Vol. 4, Iss. 3, pp. 186-192
Open Access | Times Cited: 5
The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein
Matthew R. Freidel, Pratiti A. Vakhariya, Shalinder K. Sardarni, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 640-640
Open Access
Anti-Coronavirus Potential of Polyether Ionophores: The New Application of Veterinary Antibiotics in Livestock
Youle Zheng, Jin Feng, Yixin Yu, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 18, pp. 10640-10654
Closed Access
Continuous Flow Enabled Synthesis of Multiresistant Drug Clofazimine
Rajat Pandey, Faith M. Akwi, Paul Watts
Organic Process Research & Development (2024) Vol. 28, Iss. 11, pp. 4163-4172
Open Access
Computational Structure-Based Design of Antiviral Peptides as Potential Protein–Protein Interaction Inhibitors of Rabies Virus Phosphoprotein and Human LC8
Saman Rahmati, Fatemeh Zandi, Khadijeh Ahmadi, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41520-e41520
Open Access
Multi‐Targeted Antivirals
Bing Ye, Letian Song, Meehyein Kim, et al.
(2024), pp. 405-421
Closed Access
Discovery of new riminophenazine analogues as antimycobacterial agents against drug-resistant Mycobacterium tuberculosis
Xiao‐Qiang Zhao, Yuheng Mei, Zhihao Guo, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 105929-105929
Closed Access | Times Cited: 2
Page 1

Scroll to top